15 results on '"Dwivedi, Girish"'
Search Results
2. Advances in Cellular and Tissue based Imaging Techniques for Sarcoid Granulomas
- Author
-
Kim, Junwoo, primary, Dwivedi, Girish, additional, Boughton, Berin A, additional, Sharma, Ankur, additional, and Lee, Silvia, additional
- Published
- 2023
- Full Text
- View/download PDF
3. The role of the host-microbiome and metabolomics in sarcoidosis
- Author
-
Kim, Junwoo, primary, Lee, Silvia, additional, Moodley, Yuben, additional, Yagnik, Lokesh, additional, Birnie, David, additional, and Dwivedi, Girish, additional
- Published
- 2023
- Full Text
- View/download PDF
4. Atherosclerosis as the Damocles' sword of human evolution: insights from nonhuman ape-like primates, ancient human remains, and isolated modern human populations.
- Author
-
Kumar, Annora Ai-Wei, Huangfu, Gavin, Figtree, Gemma A., and Dwivedi, Girish
- Subjects
HUMAN evolution ,ARCHAEOLOGICAL human remains ,ATHEROSCLEROSIS ,LDL cholesterol ,SOMATIC mutation ,CARDIOVASCULAR diseases risk factors - Abstract
Atherosclerosis is the leading cause of death worldwide, and the predominant risk factors are advanced age and high-circulating low-density lipoprotein cholesterol (LDL-C). However, the findings of atherosclerosis in relatively young mummified remains and a lack of atherosclerosis in chimpanzees despite high LDL-C call into question the role of traditional cardiovascular risk factors. The inflammatory theory of atherosclerosis may explain the discrepancies between traditional risk factors and observed phenomena in current literature. Following the divergence from chimpanzees several millennia ago, loss of function mutations in immune regulatory genes and changes in gene expression have resulted in an overactive human immune system. The ubiquity of atherosclerosis in the modern era may reflect a selective pressure that enhanced the innate immune response at the cost of atherogenesis and other chronic disease states. Evidence provided from the fields of genetics, evolutionary biology, and paleoanthropology demonstrates a sort of circular dependency between inflammation, immune system functioning, and evolution at both a species and cellular level. More recently, the role of proinflammatory stimuli, somatic mutations, and the gene-environment effect appear to be underappreciated elements in the development and progression of atherosclerosis. Neurobiological stress, metabolic syndrome, and traditional cardiovascular risk factors may instead function as intermediary links between inflammation and atherosclerosis. Therefore, considering evolution as a mechanistic process and atherosclerosis as part of the inertia of evolution, greater insight into future preventative and therapeutic interventions for atherosclerosis can be gained by examining the past. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
5. Gut microbiota and metabolomics profiles in patients with chronic stable angina and acute coronary syndrome
- Author
-
Ahmad, Adilah F., primary, Caparrós-Martin, Jose A., additional, Gray, Nicola, additional, Lodge, Samantha, additional, Wist, Julien, additional, Lee, Silvia, additional, O'Gara, Fergal, additional, Dwivedi, Girish, additional, and Ward, Natalie C., additional
- Published
- 2023
- Full Text
- View/download PDF
6. Advances in cellular and tissue-based imaging techniques for sarcoid granulomas.
- Author
-
Junwoo Kim, Dwivedi, Girish, Boughton, Berin A., Sharma, Ankur, and Silvia Lee
- Subjects
- *
CELL imaging , *DESORPTION ionization mass spectrometry , *GRANULOMA , *STAINS & staining (Microscopy) , *HEMATOXYLIN & eosin staining - Abstract
Sarcoidosis embodies a complex inflammatory disorder spanning multiple systems, with its origin remaining elusive. It manifests as the infiltration of inflammatory cells that coalesce into distinctive noncaseous granulomas within afflicted organs. Unraveling this disease necessitates the utilization of cellular or tissue-based imaging methods to both visualize and characterize the biochemistry of these sarcoid granulomas. Although hematoxylin and eosin stain, standard in routine use alongside cytological stains have found utility in diagnosis within clinical contexts, special stains such as Masson's trichrome, reticulin, methenamine silver, and Ziehl-Neelsen provide additional varied perspectives of sarcoid granuloma imaging. Immunohistochemistry aids in pinpointing specific proteins and gene expressions further characterizing these granulomas. Finally, recent advances in spatial transcriptomics promise to divulge profound insights into their spatial orientation and three-dimensional (3-D) molecular mapping. This review focuses on a range of preexisting imaging methods employed for visualizing sarcoid granulomas at the cellular level while also exploring the potential of the latest cutting-edge approaches like spatial transcriptomics and matrix-assisted laser desorption ionization mass spectrometry imaging (MALDI-MSI), with the overarching goal of shedding light on the trajectory of sarcoidosis research. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
7. Gut microbiota and metabolomics profiles in patients with chronic stable angina and acute coronary syndrome.
- Author
-
Ahmad, Adilah F., Caparros-Martin, Jose A., Gray, Nicola, Lodge, Samantha, Wist, Julien, Lee, Silvia, O'Gara, Fergal, Dwivedi, Girish, and Ward, Natalie C.
- Subjects
GUT microbiome ,ACUTE coronary syndrome ,BACTERIAL metabolites ,ANGINA pectoris ,METABOLOMICS ,BACTERIAL diversity - Abstract
Cardiovascular disease (CVD) is the leading cause of death worldwide. The gut microbiota and its associated metabolites may be involved in the development and progression of CVD, although the mechanisms and impact on clinical outcomes are not fully understood. This study investigated the gut microbiome profile and associated metabolites in patients with chronic stable angina (CSA) and acute coronary syndrome (ACS) compared with healthy controls. Bacterial alpha diversity in stool from patients with ACS or CSA was comparable to healthy controls at both baseline and follow-up visits. Differential abundance analysis identified operational taxonomic units (OTUs) assigned to commensal taxa differentiating patients with ACS from healthy controls at both baseline and follow-up. Patients with CSA and ACS had significantly higher levels of trimethylamine N-oxide compared with healthy controls (CSA: 0.032 ± 0.023 mmol/L, P < 0.01 vs. healthy, and ACS: 0.032 ± 0.023 mmol/L, P ¼ 0.02 vs. healthy, respectively). Patients with ACS had reduced levels of propionate and butyrate (119 ± 4 vs. 139 ± 5.1 lM, P ¼ 0.001, and 14 ± 4.3 vs. 23.5 ± 8.1 lM, P < 0.001, respectively), as well as elevated serum sCD14 (2245 ± 75.1 vs. 1834 ± 45.8 ng/mL, P < 0.0001) and sCD163 levels (457.3 ± 31.8 vs. 326.8 ± 20.7 ng/mL, P ¼ 0.001), compared with healthy controls at baseline. Furthermore, a modi- fied small molecule metabolomic and lipidomic signature was observed in patients with CSA and ACS compared with healthy controls. These findings provide evidence of a link between gut microbiome composition and gut bacterial metabolites with CVD. Future time course studies in patients to observe temporal changes and subsequent associations with gut microbiome composition are required to provide insight into how these are affected by transient changes following an acute coronary event. NEW & NOTEWORTHY The study found discriminative microorganisms differentiating patients with acute coronary syndrome (ACS) from healthy controls. In addition, reduced levels of certain bacterial metabolites and elevated sCD14 and sCD163 were observed in patients with ACS compared with healthy controls. Furthermore, modified small molecule metabolomic and lipidomic signatures were found in both patient groups. Although it is not known whether these differences in profiles are associated with disease development and/or progression, the findings provide exciting options for potential new disease-related mechanism(s) and associated therapeutic target(s). [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
8. The role of the host-microbiome and metabolomics in sarcoidosis.
- Author
-
Junwoo Kim, Lee, Silvia, Moodley, Yuben, Yagnik, Lokesh, Birnie, David, and Dwivedi, Girish
- Subjects
SARCOIDOSIS ,MACROPHAGES ,POLLUTANTS ,LYMPH nodes ,METABOLOMICS - Abstract
Sarcoidosis is a complex inflammatory fibrotic disease that affects multiple organ systems. It is characterized by the infiltration of lymphocytes and mononuclear phagocytes, which form non-caseating granulomas in affected organs. The lungs and intrathoracic lymph nodes are the most commonly affected organs. The underlying cause of sarcoidosis is unknown, but it is believed to occur in genetically predisposed individuals who are exposed to pathogenic organisms, environmental contaminants, or self and non-self-antigens. Recent research has suggested that the microbiome may play a role in the development of respiratory conditions, including sarcoidosis. Additionally, metabolomic studies have identified potential biomarkers for monitoring sarcoidosis progression. This review will focus on recent microbiome and metabolomic findings in sarcoidosis, with the goal of shedding light on the pathogenesis and possible diagnostic and therapeutic approaches. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
9. The gut microbiome and cardiovascular disease: current knowledge and clinical potential
- Author
-
Ahmad, Adilah F., primary, Dwivedi, Girish, additional, O’Gara, Fergal, additional, Caparros-Martin, Jose, additional, and Ward, Natalie C., additional
- Published
- 2019
- Full Text
- View/download PDF
10. Macrophages and T cells in atherosclerosis: a translational perspective
- Author
-
Bartlett, Benjamin, primary, Ludewick, Herbert P., additional, Misra, Ashish, additional, Lee, Silvia, additional, and Dwivedi, Girish, additional
- Published
- 2019
- Full Text
- View/download PDF
11. Advances in cellular and tissue-based imaging techniques for sarcoid granulomas.
- Author
-
Kim J, Dwivedi G, Boughton BA, Sharma A, and Lee S
- Subjects
- Humans, Granuloma diagnostic imaging, Sarcoidosis diagnostic imaging
- Abstract
Sarcoidosis embodies a complex inflammatory disorder spanning multiple systems, with its origin remaining elusive. It manifests as the infiltration of inflammatory cells that coalesce into distinctive noncaseous granulomas within afflicted organs. Unraveling this disease necessitates the utilization of cellular or tissue-based imaging methods to both visualize and characterize the biochemistry of these sarcoid granulomas. Although hematoxylin and eosin stain, standard in routine use alongside cytological stains have found utility in diagnosis within clinical contexts, special stains such as Masson's trichrome, reticulin, methenamine silver, and Ziehl-Neelsen provide additional varied perspectives of sarcoid granuloma imaging. Immunohistochemistry aids in pinpointing specific proteins and gene expressions further characterizing these granulomas. Finally, recent advances in spatial transcriptomics promise to divulge profound insights into their spatial orientation and three-dimensional (3-D) molecular mapping. This review focuses on a range of preexisting imaging methods employed for visualizing sarcoid granulomas at the cellular level while also exploring the potential of the latest cutting-edge approaches like spatial transcriptomics and matrix-assisted laser desorption ionization mass spectrometry imaging (MALDI-MSI), with the overarching goal of shedding light on the trajectory of sarcoidosis research.
- Published
- 2024
- Full Text
- View/download PDF
12. Insights into the associations between the gut microbiome, its metabolites, and heart failure.
- Author
-
Ahmad AF, Caparrós-Martin JA, Gray N, Lodge S, Wist J, Lee S, O'Gara F, Shah A, Ward NC, and Dwivedi G
- Subjects
- Humans, Stroke Volume, Ventricular Function, Left, Gastrointestinal Microbiome, Heart Failure, Microbiota
- Abstract
Heart failure (HF) is the end stage of most cardiovascular diseases and remains a significant health problem globally. We aimed to assess whether patients with left ventricular ejection fraction ≤45% had alterations in both the gut microbiome profile and production of associated metabolites when compared with a healthy cohort. We also examined the associated inflammatory, metabolomic, and lipidomic profiles of patients with HF. This single center, observational study, recruited 73 patients with HF and 59 healthy volunteers. Blood and stool samples were collected at baseline and 6-mo follow-up, along with anthropometric and clinical data. When compared with healthy controls, patients with HF had reduced gut bacterial alpha diversity at follow-up ( P = 0.004) but not at baseline. The stool microbiota of patients with HF was characterized by a depletion of operational taxonomic units representing commensal Clostridia at both baseline and follow-up. Patients with HF also had significantly elevated baseline plasma acetate ( P = 0.007), plasma trimethylamine- N -oxide (TMAO) ( P = 0.003), serum soluble CD14 (sCD14; P = 0.005), and soluble CD163 (sCD163; P = 0.004) levels compared with healthy controls. Furthermore, patients with HF had a distinct metabolomic and lipidomic profile at baseline when compared with healthy controls. Differences in the composition of the gut microbiome and the levels of associated metabolites were observed in patients with HF when compared with a healthy cohort. This was also associated with an altered metabolomic and lipidomic profile. Our study identifies microorganisms and metabolites that could represent new therapeutic targets and diagnostic tools in the pathogenesis of HF. NEW & NOTEWORTHY We found a reduction in gut bacterial alpha diversity in patients with heart failure (HF) and that the stool microbiota of patients with HF was characterized by depletion of operational taxonomic units representing commensal Clostridia at both baseline and follow-up. Patients with HF also had altered bacterial metabolites and increased inflammatory profiles compared with healthy controls. A distinct metabolomic and lipidomic profile was present in patients with HF at baseline when compared with healthy controls.
- Published
- 2023
- Full Text
- View/download PDF
13. The role of the host-microbiome and metabolomics in sarcoidosis.
- Author
-
Kim J, Lee S, Moodley Y, Yagnik L, Birnie D, and Dwivedi G
- Subjects
- Humans, Lung pathology, Sarcoidosis diagnosis, Sarcoidosis drug therapy, Sarcoidosis pathology
- Abstract
Sarcoidosis is a complex inflammatory fibrotic disease that affects multiple organ systems. It is characterized by the infiltration of lymphocytes and mononuclear phagocytes, which form non-caseating granulomas in affected organs. The lungs and intrathoracic lymph nodes are the most commonly affected organs. The underlying cause of sarcoidosis is unknown, but it is believed to occur in genetically predisposed individuals who are exposed to pathogenic organisms, environmental contaminants, or self and non-self-antigens. Recent research has suggested that the microbiome may play a role in the development of respiratory conditions, including sarcoidosis. Additionally, metabolomic studies have identified potential biomarkers for monitoring sarcoidosis progression. This review will focus on recent microbiome and metabolomic findings in sarcoidosis, with the goal of shedding light on the pathogenesis and possible diagnostic and therapeutic approaches.
- Published
- 2023
- Full Text
- View/download PDF
14. The gut microbiome and cardiovascular disease: current knowledge and clinical potential.
- Author
-
Ahmad AF, Dwivedi G, O'Gara F, Caparros-Martin J, and Ward NC
- Subjects
- Animals, Anti-Bacterial Agents therapeutic use, Arteries metabolism, Arteries pathology, Atherosclerosis metabolism, Atherosclerosis pathology, Atherosclerosis therapy, Diet, Healthy, Dietary Supplements, Dysbiosis, Fecal Microbiota Transplantation, Host-Pathogen Interactions, Humans, Plaque, Atherosclerotic, Signal Transduction, Arteries microbiology, Atherosclerosis microbiology, Bacteria metabolism, Gastrointestinal Microbiome, Intestines microbiology
- Abstract
Cardiovascular disease (CVD) is the leading cause of death worldwide. The human body is populated by a diverse community of microbes, dominated by bacteria, but also including viruses and fungi. The largest and most complex of these communities is located in the gastrointestinal system and, with its associated genome, is known as the gut microbiome. Gut microbiome perturbations and related dysbiosis have been implicated in the progression and pathogenesis of CVD, including atherosclerosis, hypertension, and heart failure. Although there have been advances in the characterization and analysis of the gut microbiota and associated bacterial metabolites, the exact mechanisms through which they exert their action are not well understood. This review will focus on the role of the gut microbiome and associated functional components in the development and progression of atherosclerosis. Potential treatments to alter the gut microbiome to prevent or treat atherosclerosis and CVD are also discussed.
- Published
- 2019
- Full Text
- View/download PDF
15. Macrophages and T cells in atherosclerosis: a translational perspective.
- Author
-
Bartlett B, Ludewick HP, Misra A, Lee S, and Dwivedi G
- Subjects
- Animals, Arteries metabolism, Arteries pathology, Atherosclerosis metabolism, Atherosclerosis pathology, Cell Lineage, Cytokines immunology, Cytokines metabolism, Humans, Lymphocyte Activation, Macrophage Activation, Macrophages metabolism, Phenotype, Plaque, Atherosclerotic, Signal Transduction, T-Lymphocyte Subsets metabolism, Translational Research, Biomedical, Arteries immunology, Atherosclerosis immunology, Macrophages immunology, T-Lymphocyte Subsets immunology
- Abstract
Atherosclerosis is now considered a chronic maladaptive inflammatory disease. The hallmark feature in both human and murine disease is atherosclerotic plaques. Macrophages and various T-cell lineages play a crucial role in atherosclerotic plaque establishment and disease progression. Humans and mice share many of the same processes that occur within atherogenesis. The various similarities enable considerable insight into disease mechanisms and those which contribute to cardiovascular complications. The apolipoprotein E-null and low-density lipoprotein receptor-null mice have served as the foundation for further immunological pathway manipulation to identify pro- and antiatherogenic pathways in attempt to reveal more novel therapeutic targets. In this review, we provide a translational perspective and discuss the roles of macrophages and various T-cell lineages in contrasting proatherosclerotic and atheroprotective settings.
- Published
- 2019
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.